Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-01-10

Clinical Trial Update: Efficacy and Safety of Voclosporin to Treat Active Noninfectious Uveitis [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluate the efficacy and safety of voclosporin for active noninfectious uveitis. The study sponsored by Lux Biosciences has reached compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Voclosporin (voclosporin)

Snippet

Sponsor: Lux Biosciences, Inc. | Conditions: Noninfectious Uveitis | Phase 3 | Status: COMPLETED